Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in mild Alzheimer's disease
ChiCTR1800018478Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Alzheimer's disease (AD) comparing Idebenone treatment group with Placebo control group (2 arms). Primary endpoints: Cerebral metabolic rate of glucose, Aβ40 and 5 more. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
idebenone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on ChiCTR1800018478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018478.